Diisopropylethylamine → 3-Bromo-8-fluoro-7-[2-(triethylsilyloxy)prop-2-yl]imidazo[1,2-alpha]pyridine

HRID 1765098Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1765098
CCN(C(C)C)C(C)C.FC(F)(F)S([O:15][Si:16]([CH2:21][CH3:22])([CH2:19][CH3:20])[CH2:17][CH3:18])(=O)=O.[Br:25][C:26]1[N:30]2[CH:31]=[CH:32][C:33]([C:36](O)([CH3:38])[CH3:37])=[C:34]([F:35])[C:29]2=[N:28][CH:27]=1>C(Cl)Cl>[Br:25][C:26]1[N:30]2[CH:31]=[CH:32][C:33]([C:36]([O:15][Si:16]([CH2:17][CH3:18])([CH2:19][CH3:20])[CH2:21][CH3:22])([CH3:38])[CH3:37])=[C:34]([F:35])[C:29]2=[N:28][CH:27]=1

Komponenten

5

Versuchsvorschrift

Hünig's base (0.44 ml, 3.8 mmol) and triethylsilyl trifluoromethane-sulfonate (0.57 ml, 2.6 mmol) were added sequentially to a cold (−78° C.), stirred solution of 2-(3-bromo-8-fluoroimidazo[1,2-α]pyridin-7-yl)propan-2-ol (637 mg, 2.3 mmol) in CH2Cl2 (13 ml) and the solution warmed to ambient temperature. The mixture was partitioned between CH2Cl2 (50 ml) and water (50 ml) and the organic phase dried over anhydrous MgSO4, filtered through a short plug of silica (eluent CH2Cl2) and concentrated to afford 3-bromo-8-fluoro-7-[2-(triethylsilyloxy)prop-2-yl]imidazo[1,2-α]pyridine (906 mg, quant.): δH (360 MHz, CDCl3) 0.70 (6H, q, J 7.8), 0.99 (9H, t, J 7.8), 1.71 (6H, s), 7.32 (1H, t, J 6.9), 7.59 (1H, s), 7.88 (1H, d, J 7.3).

Aufarbeitung

  1. customThe mixture was partitioned between CH2Cl2 (50 ml) and water (50 ml)
  2. dry with materialthe organic phase dried over anhydrous MgSO4
  3. filtrationfiltered through a short plug of silica (eluent CH2Cl2)
  4. concentrationconcentrated

Quellen und Nachweise

ORD-Eintrag
ord-0bd70a30a49447ed91a953966756e0ec
Quelldatensatz
uspto-grants-2007_06
Patentnummer
US07226926B2

Notizen zur Reaktion

Wird geladen…